Com7 PCL (BKK:COM7)

Intra-Cellular Therapies Revenue

Com7 PCL had revenue of 20.95B THB in the quarter ending March 31, 2025, with 8.70% growth. This brings the company's revenue in the last twelve months to 80.94B, up 12.95% year-over-year. In the year 2024, Com7 PCL had annual revenue of 79.26B with 13.73% growth.

• Revenue (ttm): 80.94B
• Revenue Growth: +12.95%
• P/S Ratio: 0.69
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 55.81B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	79.26B	9.57B	13.73%
Dec 31, 2023	69.69B	6.67B	10.58%
Dec 31, 2022	63.03B	11.88B	23.22%
Dec 31, 2021	51.15B	13.80B	36.94%
Dec 31, 2020	37.35B	3.96B	11.87%